Cme Group INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NASDAQ
CME Group Inc. announced its financial results for the second quarter and first six months ended June 30, 2026, showing a slight increase in net income and revenue growth driven by market data services.
NASDAQ
CME Group reported a 21% increase in net income for Q1 2026, driven by heightened market volatility and increased trading volumes across all asset classes.
NASDAQ
CME Group reports a 3% decline in Q3 2025 total revenues but a 6% increase for the nine months, driven by higher investment income and market data growth despite lower trading volumes.
NASDAQ
10-Q: CME Group Reports Strong Q2 2025 Earnings Driven by Surging Trading Volumes and Investment Income
CME Group Inc. announced a significant increase in net income and revenues for the second quarter and first half of 2025, fueled by higher trading volumes across key product lines and robust investment income from performance bonds.
NASDAQ
CME Group's Q1 2025 earnings surged, fueled by a significant increase in trading volumes across various product lines.
NASDAQ
CME Group's Q3 2024 results show a significant increase in revenue and net income, driven by higher trading volumes across various product lines.
NASDAQ
CME Group's Q2 2024 results show a significant increase in revenue and net income, driven by higher trading volumes across various product lines.
NASDAQ
CME Group's first quarter 2024 results show a slight increase in revenue but a decrease in net income compared to the same period last year, influenced by market volatility and changes in trading volumes.